AvengeBio
Cambridge
About AvengeBio
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. It is a developer of a drug delivery platform intended to treat cancer. The company was founded in 2019 and based in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: avengebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/avengebio-60043 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.